Concepedia

R Brickl

RB

Statistics

Publications

6

Citations

304

H-Index

6

Active since

1990

Affiliations

Boehringer Ingelheim (Germany)(Current)

Goethe University Frankfurt

R Brickl is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, medicine, and biorelevant dissolution testing.

Publications per year

1990–2009

6

Publications

6

Dipyridamole alone or combined with low‐dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo [see comments]

Thomas Müller, C Y Su, H Weisenberger et al. · British Journal of Clinical Pharmacology · 1990 · 86 citations · Full text

, , +14

Profound and Sustained Inhibition of Platelet Aggregation by Fradafiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, and Its Orally Active Prodrug, Lefradafiban, in Men

Thomas Müller, H Weisenberger, R Brickl et al. · Circulation · 1997 · 79 citations

, , +17

Is bicarbonate buffer suitable as a dissolution medium?

Julia Elisabeth Boni, R Brickl, Jennifer Dressman · Journal of Pharmacy and Pharmacology · 2007 · 55 citations · Full text

, , +17

Instant FaSSIF and FeSSIF—Biorelevance Meets Practicality

Julia Elisabeth Boni, R Brickl, Jennifer Dressman et al. · Dissolution Technologies · 2009 · 33 citations · Full text

, , +17

Pharmacokinetics of Single‐Dose Telmisartan 120 mg Given during and between Hemodialysis in Subjects with Severe Renal Insufficiency: Comparison with Healthy Volunteers

Joachim Stangier, Chung‐An P. F. Su, R Brickl et al. · The Journal of Clinical Pharmacology · 2000 · 27 citations

, , +14

1–5 of 6